Oxytocin (Pitocin)

Summary

Oxytocin is a natural nonapeptide hormone approved by FDA for decades as an injection (Pitocin) to induce or augment labor and control postpartum bleeding, where its efficacy is established. The intranasal oxytocin sold by compounding pharmacies for sexual function, bonding, or social anxiety is not an FDA approved product, and randomized trials of nasal oxytocin show small and inconsistent effects: in 29 healthy couples a 24 IU dose did not change sexual drive, arousal, or erection but modestly increased orgasm intensity and post-sex contentment, and meta-analyses in autism find small effects on social functioning at best. It is not prohibited by WADA.

What is Oxytocin?

Oxytocin is an endogenous nine amino acid neuropeptide hormone (cyclic nonapeptide) produced in the hypothalamus and released from the posterior pituitary. It is also known as Pitocin, Syntocinon, Intranasal oxytocin, OXT, Compounded oxytocin nasal spray, Oxytocin nasal spray, Oxytocin peptide.

How does it work?

Oxytocin binds the oxytocin receptor, a G protein coupled receptor on uterine smooth muscle (contraction), mammary myoepithelial cells (milk ejection), and neurons in limbic and hypothalamic regions involved in social bonding, trust, sexual behavior, and stress regulation. Peripheral oxytocin crosses the blood brain barrier poorly; intranasal delivery is proposed to reach the brain through olfactory and trigeminal pathways, though how much reaches central receptors in humans is debated. Its half-life in plasma is a few minutes.

FDA-approved uses of Oxytocin

Yes, as an injection for obstetric use. Before delivery, the Pitocin label covers starting or improving uterine contractions for medical reasons, such as induction of labor with a medical indication, stimulation of labor in selected cases of uterine inertia, and as adjunctive therapy in incomplete or inevitable abortion. After delivery, it covers producing uterine contractions in the third stage of labor and controlling postpartum bleeding. It is not indicated for elective induction. No oxytocin nasal spray or lozenge is FDA approved; those are compounded. [3] [4]

What does the evidence say about Oxytocin?

For obstetric use, oxytocin is standard of care with decades of trial and label evidence for labor induction, augmentation, and prevention of postpartum hemorrhage. For the off-label uses that drive peptide clinic interest the evidence is thin: one double-blind crossover study in 29 healthy couples found intranasal oxytocin 24 IU had no effect on classical sexual function measures but small to moderate effects on orgasm intensity and post-sex contentment, larger in men. A 2021 multilevel meta-analysis of 28 studies (726 participants) in autism reported beneficial effects on social functioning but not on non-social symptoms, and later meta-analyses of randomized trials describe small and inconsistent results across mental disorders. No randomized trial supports nasal oxytocin for erectile dysfunction, low libido as a diagnosis, or relationship problems.

Human evidence

Behnia 2014: 29 heterosexual couples (58 participants), double-blind placebo-controlled crossover, intranasal oxytocin 24 IU before sexual intercourse; no change in sexual drive, arousal, erection, or lubrication; increased orgasm intensity and contentment after intercourse, more pronounced in men, with small to moderate effect sizes. Huang 2021: multilevel meta-analysis of 28 studies (n = 726) of oxytocin in autism spectrum disorder reporting benefit on social functioning but not on non-social symptoms. Labor and postpartum hemorrhage indications rest on the Pitocin label and long standing obstetric trial evidence.

Animal evidence

Rodent and vole studies established oxytocin's role in maternal behavior, pair bonding, social recognition, and sexual behavior; oxytocin receptor knockout mice show deficits in social memory. Rat studies show central oxytocin facilitates erection and ejaculation. This animal work motivated the human intranasal trials but does not translate directly to dosing or efficacy in people.

Key studies

Conditions studied

Is Oxytocin legal in the United States?

FDA and compounding status

Oxytocin injection is FDA approved (Pitocin and generics) for obstetric indications. Because oxytocin is the active ingredient of an approved drug, 503A pharmacies may compound it in other dosage forms such as nasal sprays or lozenges for individual prescriptions; these compounded products are not FDA approved, have no approved indication, and have not been shown to achieve meaningful brain levels. Oxytocin is a 9 amino acid peptide and was not among the products transitioned to biologic status in March 2020, so it remains eligible for compounding. No intranasal oxytocin product is FDA approved in the United States.

WADA status

Not WADA prohibited. Not named on the current prohibited list. Athletes should still confirm against the list in force for their season.

Regulatory timeline

No regulatory events recorded.

Full tracker for Oxytocin or the category-wide tracker.

Oxytocin dose on the FDA label

Doses below are quoted from the FDA label for its approved uses, plus the doses used in the pivotal trials where noted. The prescriber sets the dose; PeptideAgent does not recommend doses or protocols.

FDA label (Pitocin, DailyMed; hospital use): induction or stimulation of labor by intravenous infusion only, starting at 0.5 to 1 milliunit per minute and increasing by 1 to 2 milliunits per minute every 30 to 60 minutes until the desired contraction pattern is established, using an infusion pump; control of postpartum bleeding, 10 to 40 units added to a running intravenous infusion (maximum 40 units per 1,000 mL) or 10 units intramuscularly after delivery of the placenta. The label states Pitocin is not indicated for elective induction of labor. No FDA label gives an intranasal dose or any dose for sexual function, social behavior, or weight.

Routes reported

What are the side effects and interactions of Oxytocin?

Side effects

Interactions

Contraindications

How do people access Oxytocin legally?

Typical cost: Generic oxytocin injection costs about 1.52 to 4.37 USD per vial in a published cash listing and is used in hospitals. Compounded oxytocin nasal spray through licensed telehealth programs runs about 115 to 135 USD per month. Prices checked 2026-09-22.

• Oxytocin cost by channel
• Rules by state
• Verified provider directory

Compare Oxytocin

• PT-141 vs oxytocin

Frequently asked questions

Decisions about starting, stopping, or combining any treatment belong with a licensed clinician who knows your history.

From the blog

• Peptides for women, ranked by human evidence

  GLP-1 drugs, teriparatide, abaloparatide, and Vyleesi (PT-141) have real trials in women. Kisspeptin is research-only and GHK-Cu rests on small skin studies. The ranking and legal status.

• What are peptides? A plain-English guide

  Peptides are short chains of amino acids. Some are FDA approved medicines, some are compounded, and many are unapproved research chemicals. Here is how to tell them apart.

Sources

Numbered citations above point to these primary sources. PubMed entries link to the indexed abstract.